Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why
- Written by David B. Sarwer, Professor of Social and Behavioral Sciences, Temple University
Polling shows that 1 in 8 Americans have tried GLP-1 drugs.zimmytws/iStock via Getty Images PlusThe Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the monthly prices of these medications by hundreds of dollars.
For the past...


